Vaxcyte, Inc. - COM (PCVX)

Historical Portfolio Holders from Q2 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
135M
Holdings value Q3 2024
$15.5B
Value change Q3 2024
+$1.41B
Grand Portfolio weight change Q3 2024
+0.003%
Number of holders
320
Number of buys Q3 2024
203
Number of sells Q3 2024
-105
Average buys Q3 2024 %
+0.005%
Average sells Q3 2024 %
-0.005%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 135M $15.5B +$1.41B $114.27 322
2024 Q2 123M $9.26B +$348M $75.51 265
2024 Q1 118M $8.06B +$1.05B $68.31 247
2023 Q4 103M $6.47B +$118M $62.80 223
2023 Q3 101M $5.12B +$37.7M $50.98 200
2023 Q2 100M $4.99B +$865M $49.94 196
2023 Q1 84.1M $3.15B +$160M $37.48 184
2022 Q4 81.5M $3.91B +$1.14B $47.95 194
2022 Q3 56.5M $1.36B +$122M $24.00 120
2022 Q2 51.4M $1.12B +$31.3M $21.76 102
2022 Q1 49.8M $1.2B +$69M $24.15 85
2021 Q4 44.7M $1.06B +$32M $23.79 83
2021 Q3 43.2M $1.1B -$196K $25.37 76
2021 Q2 43.2M $972M -$14.1M $22.51 73
2021 Q1 44M $869M +$26.5M $19.75 73
2020 Q4 42.2M $1.12B +$57.9M $26.57 82
2020 Q3 37.8M $1.86B +$104M $49.38 60
2020 Q2 36M $1.13B +$1.13B $31.61 38